Thromboelastogram in Postdelivery Preeclamptic Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-22

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There are no studies evaluating the effect of aging on hemostasis of preeclamptic patients. Additionally, although there are some studies that establish normal reference values for TEG profiles in healthy term pregnant patients, conflicting results have been found in preeclampsia. Reference values are important to establish baseline parameters in cases of pre-eclampsia complicated by postpartum hemorrhage. The investigators will evaluate reference values for TEG in postdelivery preeclamptic patients and the difference between vaginal delivery and cesarean section.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bedside Assessment of Coagulation in Post-partum Hemorrhage by Thromboelastography (TEG ®6S)

NCT03592303

Coagulation Defect; Puerperal Post Partum Hemorrhage Blood Protein Disorders +1 more

UNKNOWN

Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia

NCT03149250

Coagulation Disorder, Blood Platelet Function

UNKNOWN

THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin

NCT06575309

Pregnant Women Venous Thromboembolic Disease

RECRUITING

Pregnancy and Risk of Venous Thromboembolism

NCT03659708

Thromboembolism Pregnancy

RECRUITING NA

State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays

NCT05625763

Pre-Eclampsia

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After approval by the Institutional Review Board and informed consent from participants, the investigators are obtaining blood samples for TEG processing, from pregnant patients admitted to the maternity unit of Augusta University Medical Center. Patients are being classified in 2 groups: term pregnant patients with diagnosis of pre-eclampsia who undergo cesarean section and those having spontaneous vaginal delivery. Each group will be divided into subgroups according to maternal age: 18-25 years, 26-35 years, \>36 years. Pre-eclampsia is defined and classified according to the definitions of the American College of Obstetricians and Gynecologists published in 2013.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preeclampsia Coagulation Disorder Pregnancy Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Post-cesarean preeclampsia

Thromboelastogram

Intervention Type DIAGNOSTIC_TEST

Blood sample processing for thromboelastogram

Post spontaneous vaginal delivery preeclampsia

Thromboelastogram

Intervention Type DIAGNOSTIC_TEST

Blood sample processing for thromboelastogram

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.